Aurinia Pharmaceuticals Inc (AUP.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Sales | 34,409 | 28,435 | 55,779 | 28,191 | 21,625 |
| Cost of Goods | 421 | 1,362 | 2,447 | 1,599 | 256 |
| Gross Profit | 33,988 | 27,073 | 53,332 | 26,592 | 21,369 |
| Operating Expenses | 63,572 | 55,173 | 62,831 | 62,581 | 59,251 |
| Operating Income | -29,584 | -28,100 | -9,499 | -35,989 | -37,882 |
| Other Income | 3,814 | 2,909 | 1,464 | 483 | 262 |
| Pre-tax Income | -25,770 | -25,191 | -8,035 | -35,506 | -37,620 |
| Income Tax | 436 | 855 | 954 | 9 | 10 |
| Net Income Continuous | -26,206 | -26,046 | -8,989 | -35,515 | -37,630 |
| Net Income | $-26,206 | $-26,046 | $-8,989 | $-35,515 | $-37,630 |
| EBITDA(a) | $-28,867 | $-27,881 | $-8,690 | $-35,149 | $-37,044 |